Leslie Meltzer
Chief Tech/Sci/R&D Officer presso ORCHARD THERAPEUTICS PLC
Posizioni attive di Leslie Meltzer
Società | Posizione | Inizio | Fine |
---|---|---|---|
ORCHARD THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01/06/2018 | - |
Storia della carriera di Leslie Meltzer
Precedenti posizioni note di Leslie Meltzer
Società | Posizione | Inizio | Fine |
---|---|---|---|
KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 01/08/2016 | 01/06/2018 |
Formazione di Leslie Meltzer
Stanford University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Regno Unito | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Leslie Meltzer
- Esperienza